Logo
csv. check, some, votes

Objection pursuant to Rule 112: Extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole (D061354)

Reference: B9-0103/2019

Date: 10.10.2019

← Previous
Next →
Filter by Country
Overall Result
Total: 751 MEPs
402 For
222 Against
39 Abstention
88 Did not vote
402 For
222 Against
39 Abstention
88 Did not vote
Sven GIEGOLD
Foto von Sven GIEGOLD

Country: Germany

Group: Greens/European Free Alliance (Greens/EFA)

Debate contributions: 0

My vote:
For
European People's Party (EPP)
For: 27
Against: 130
Abstention: 2
Did not vote: 23
Click for details
Progressive Alliance of Socialists and Democrats (S&D)
For: 137
Against: 0
Abstention: 3
Did not vote: 14
Click for details
Renew Europe (Renew)
For: 56
Against: 34
Abstention: 7
Did not vote: 11
Click for details
Greens/European Free Alliance (Greens/EFA)
For: 68
Against: 0
Abstention: 0
Did not vote: 6
Click for details
Identity and Democracy (ID)
For: 50
Against: 13
Abstention: 0
Did not vote: 10
Click for details
European Conservatives and Reformists (ECR)
For: 4
Against: 43
Abstention: 2
Did not vote: 13
Click for details
Non-attached Members (NI)
For: 21
Against: 2
Abstention: 25
Did not vote: 9
Click for details
The Left in the European Parliament (GUE/NGL)
For: 39
Against: 0
Abstention: 0
Did not vote: 2
Click for details
←